跳至主要内容
临床试验/NCT05638841
NCT05638841招募中不适用

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Compound cardiovascular event

研究概览

简要总结

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18
  • ECG or holter electrocardiogram confirmed atrial fibrillation

排除标准

  • Hematological diseases, autoimmune diseases and malignant tumors
  • Immobility caused by hemiplegia or severe trauma
  • The expected survival time is less than 2 years
  • Poor compliance and high risk of expected loss of follow-up
  • Disorders of consciousness or Alzheimer's disease

结局指标

主要结局

Compound cardiovascular event

时间窗: 24 months

Stroke, hemorrhage, re-hospitalization for atrial fibrillation and heart failure, and all-cause death

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验